{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:18:04Z","timestamp":1785543484520,"version":"3.56.0"},"reference-count":172,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T00:00:00Z","timestamp":1727136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T00:00:00Z","timestamp":1727136000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100009392","name":"Prince Sattam bin Abdulaziz University","doi-asserted-by":"publisher","award":["PSAU\/2023\/R\/1445"],"award-info":[{"award-number":["PSAU\/2023\/R\/1445"]}],"id":[{"id":"10.13039\/100009392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009392","name":"Prince Sattam bin Abdulaziz University","doi-asserted-by":"publisher","award":["PSAU\/2023\/R\/1445"],"award-info":[{"award-number":["PSAU\/2023\/R\/1445"]}],"id":[{"id":"10.13039\/100009392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Physiol Biochem"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1007\/s13105-024-01050-x","type":"journal-article","created":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T08:02:08Z","timestamp":1727164928000},"page":"811-829","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["MicroRNA-enriched exosome as dazzling dancer between cancer and immune cells"],"prefix":"10.1007","volume":"80","author":[{"given":"Chou-Yi","family":"Hsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulrahman T.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Hjazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussein Riyadh Abdul Kareem","family":"Al-Hetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maytham T.","family":"Qasim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrokhim","family":"Sapaev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahamedha","family":"Deorari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasser Fakri","family":"Mustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Elawady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,24]]},"reference":[{"key":"1050_CR1","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s13045-020-00987-y","volume":"13","author":"L Zhu","year":"2020","unstructured":"Zhu L, Sun HT, Wang S, Huang SL, Zheng Y, Wang CQ, Hu BY, Qin W, Zou TT, Fu Y et al (2020) Isolation and characterization of exosomes for cancer research. J Hematol Oncol 13:152","journal-title":"J Hematol Oncol"},{"key":"1050_CR2","doi-asserted-by":"publisher","first-page":"1130033","DOI":"10.3389\/fimmu.2023.1130033","volume":"14","author":"Q Zhou","year":"2023","unstructured":"Zhou Q, Wei S, Wang H, Li Y, Fan S, Cao Y, Wang C (2023) T cell-derived exosomes in tumor immune modulation and immunotherapy. Front Immunol 14:1130033","journal-title":"Front Immunol"},{"key":"1050_CR3","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.1021\/acs.molpharmaceut.2c00407","volume":"19","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Liu T, Zhou M (2022) Immune-Cell-Derived exosomes for Cancer Therapy. Mol Pharm 19:3042\u20133056","journal-title":"Mol Pharm"},{"key":"1050_CR4","first-page":"897","volume":"24","author":"X Zhang","year":"2019","unstructured":"Zhang X, Zhou C (2019) The function of tumor-derived exosomes. J BUON: Official J Balkan Union Oncol 24:897\u2013904","journal-title":"J BUON: Official J Balkan Union Oncol"},{"key":"1050_CR5","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.bbcan.2019.04.004","volume":"1871","author":"L Zhang","year":"2019","unstructured":"Zhang L, Yu D (2019) Exosomes in cancer development, metastasis, and immunity. Biochim et Biophys acta Reviews cancer 1871:455\u2013468","journal-title":"Biochim et Biophys acta Reviews cancer"},{"key":"1050_CR6","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1146\/annurev-biochem-013118-111902","volume":"88","author":"DM Pegtel","year":"2019","unstructured":"Pegtel DM, Gould SJ (2019) Exosomes. Annu Rev Biochem 88:487\u2013514","journal-title":"Annu Rev Biochem"},{"key":"1050_CR7","doi-asserted-by":"crossref","unstructured":"Xie QH, Zheng JQ, Ding JY, Wu YF, Liu L, Yu ZL, Chen G (2022) Exosome-Mediated Immunosuppression in Tumor Microenvironments. Cells 11","DOI":"10.3390\/cells11121946"},{"key":"1050_CR8","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.devcel.2019.04.011","volume":"49","author":"I Wortzel","year":"2019","unstructured":"Wortzel I, Dror S, Kenific CM, Lyden D (2019) Exosome-mediated metastasis: communication from a Distance. Dev Cell 49:347\u2013360","journal-title":"Dev Cell"},{"key":"1050_CR9","doi-asserted-by":"publisher","first-page":"301","DOI":"10.2147\/JIR.S421649","volume":"17","author":"R Zhang","year":"2024","unstructured":"Zhang R, Li M, Li H, Ran X, Jin F, Tan Q, Chen Z (2024) Immune Cell-Derived exosomes in Inflammatory Disease and Inflammatory Tumor Microenvironment: a review. J Inflamm Res 17:301\u2013312","journal-title":"J Inflamm Res"},{"key":"1050_CR10","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s40364-022-00374-4","volume":"10","author":"A Hazrati","year":"2022","unstructured":"Hazrati A, Soudi S, Malekpour K, Mahmoudi M, Rahimi A, Hashemi SM, Varma RS (2022) Immune cells-derived exosomes function as a double-edged sword: role in disease progression and their therapeutic applications. Biomark Res 10:30","journal-title":"Biomark Res"},{"key":"1050_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-020-01278-3","volume":"19","author":"Z Xu","year":"2020","unstructured":"Xu Z, Zeng S, Gong Z, Yan Y (2020) Exosome-based immunotherapy: a promising approach for cancer treatment. Mol Cancer 19:1\u201316","journal-title":"Mol Cancer"},{"key":"1050_CR12","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.semcancer.2019.04.004","volume":"64","author":"C Xiao","year":"2020","unstructured":"Xiao C, Nemazee D, Gonzalez-Martin A (2020) MicroRNA control of B cell tolerance, autoimmunity and cancer. Sem Cancer Biol 64:102\u2013107","journal-title":"Sem Cancer Biol"},{"key":"1050_CR13","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1186\/s12967-019-2058-1","volume":"17","author":"S Xu","year":"2019","unstructured":"Xu S, Xu H, Wang W, Li S, Li H, Li T, Zhang W, Yu X, Liu L (2019) The role of collagen in cancer: from bench to bedside. J Translational Med 17:309","journal-title":"J Translational Med"},{"key":"1050_CR14","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12943-015-0302-8","volume":"14","author":"AM Rusek","year":"2015","unstructured":"Rusek AM, Abba M, Eljaszewicz A, Moniuszko M, Niklinski J, Allgayer H (2015) MicroRNA modulators of epigenetic regulation, the tumor microenvironment and the immune system in lung cancer. Mol Cancer 14:34","journal-title":"Mol Cancer"},{"key":"1050_CR15","doi-asserted-by":"publisher","first-page":"3085","DOI":"10.1038\/onc.2014.254","volume":"34","author":"HI Suzuki","year":"2015","unstructured":"Suzuki HI, Katsura A, Matsuyama H, Miyazono K (2015) MicroRNA regulons in tumor microenvironment. Oncogene 34:3085\u20133094","journal-title":"Oncogene"},{"key":"1050_CR16","doi-asserted-by":"publisher","first-page":"3133","DOI":"10.1016\/j.ymthe.2022.01.046","volume":"30","author":"Z Xu","year":"2022","unstructured":"Xu Z, Chen Y, Ma L, Chen Y, Liu J, Guo Y, Yu T, Zhang L, Zhu L, Shu Y (2022) Role of exosomal non-coding RNAs from tumor cells and tumor-associated macrophages in the tumor microenvironment. Mol Therapy: J Am Soc Gene Therapy 30:3133\u20133154","journal-title":"Mol Therapy: J Am Soc Gene Therapy"},{"key":"1050_CR17","doi-asserted-by":"publisher","first-page":"3262","DOI":"10.4161\/cc.26087","volume":"12","author":"J Chou","year":"2013","unstructured":"Chou J, Shahi P, Werb Z (2013) microRNA-mediated regulation of the tumor microenvironment. Cell Cycle (Georgetown Tex) 12:3262\u20133271","journal-title":"Cell Cycle (Georgetown Tex)"},{"key":"1050_CR18","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s12943-022-01682-x","volume":"21","author":"P Nallasamy","year":"2022","unstructured":"Nallasamy P, Nimmakayala RK, Parte S, Are AC, Batra SK, Ponnusamy MP (2022) Tumor microenvironment enriches the stemness features: the architectural event of therapy resistance and metastasis. Mol Cancer 21:225","journal-title":"Mol Cancer"},{"key":"1050_CR19","doi-asserted-by":"crossref","unstructured":"Wang J, Wang Q, Guan Y, Sun Y, Wang X, Lively K, Wang Y, Luo M, Kim JA, Murphy EA et al (2022) Breast cancer cell-derived microRNA-155 suppresses tumor progression via enhancing immune cell recruitment and antitumor function. The Journal of clinical investigation 132","DOI":"10.1172\/JCI157248"},{"key":"1050_CR20","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.canlet.2019.04.015","volume":"454","author":"JK Wang","year":"2019","unstructured":"Wang JK, Wang Z, Li G (2019) MicroRNA-125 in immunity and cancer. Cancer Lett 454:134\u2013145","journal-title":"Cancer Lett"},{"key":"1050_CR21","doi-asserted-by":"publisher","first-page":"107990","DOI":"10.1016\/j.intimp.2021.107990","volume":"100","author":"S Wang","year":"2021","unstructured":"Wang S, Gao Y (2021) Pancreatic cancer cell-derived microRNA-155-5p-containing extracellular vesicles promote immune evasion by triggering EHF-dependent activation of Akt\/NF-\u03baB signaling pathway. Int Immunopharmacol 100:107990","journal-title":"Int Immunopharmacol"},{"key":"1050_CR22","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/978-3-031-08356-3_3","volume":"1385","author":"RN Veiga","year":"2022","unstructured":"Veiga RN, Zambalde \u00c9P, Cox L, Jucoski TS, Kohler AF, Carvalho TM, Rodrigues AC, Ludwig B, Crowley K, de Oliveira JC et al (2022) Regulation of Immune cells by microRNAs and microRNA-Based Cancer Immunotherapy. Adv Exp Med Biol 1385:75\u2013108","journal-title":"Adv Exp Med Biol"},{"key":"1050_CR23","doi-asserted-by":"publisher","first-page":"111528","DOI":"10.1016\/j.biopha.2021.111528","volume":"138","author":"BM Hussen","year":"2021","unstructured":"Hussen BM, Hidayat HJ, Salihi A, Sabir DK, Taheri M, Ghafouri-Fard S (2021) MicroRNA: a signature for cancer progression. Biomed Pharmacotherapy = Biomedecine Pharmacotherapie 138:111528","journal-title":"Biomed Pharmacotherapy = Biomedecine Pharmacotherapie"},{"key":"1050_CR24","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.molonc.2012.09.006","volume":"6","author":"MD Jansson","year":"2012","unstructured":"Jansson MD, Lund AH (2012) MicroRNA and cancer. Mol Oncol 6:590\u2013610","journal-title":"Mol Oncol"},{"key":"1050_CR25","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrd.2016.246","volume":"16","author":"R Rupaimoole","year":"2017","unstructured":"Rupaimoole R, Slack FJ (2017) MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat Rev Drug Discovery 16:203\u2013222","journal-title":"Nat Rev Drug Discovery"},{"key":"1050_CR26","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.trecan.2020.02.013","volume":"6","author":"W Yan","year":"2020","unstructured":"Yan W, Jiang S (2020) Immune Cell-Derived exosomes in the Cancer-Immunity cycle. Trends cancer 6:506\u2013517","journal-title":"Trends cancer"},{"key":"1050_CR27","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13045-022-01305-4","volume":"15","author":"MDA Paskeh","year":"2022","unstructured":"Paskeh MDA, Entezari M, Mirzaei S, Zabolian A, Saleki H, Naghdi MJ, Sabet S, Khoshbakht MA, Hashemi M, Hushmandi K et al (2022) Emerging role of exosomes in cancer progression and tumor microenvironment remodeling. J Hematol Oncol 15:83","journal-title":"J Hematol Oncol"},{"key":"1050_CR28","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.trecan.2020.03.002","volume":"6","author":"SM Morrissey","year":"2020","unstructured":"Morrissey SM, Yan J (2020) Exosomal PD-L1: roles in Tumor Progression and Immunotherapy. Trends cancer 6:550\u2013558","journal-title":"Trends cancer"},{"key":"1050_CR29","doi-asserted-by":"publisher","first-page":"e12857","DOI":"10.1111\/cpr.12857","volume":"53","author":"B Yue","year":"2020","unstructured":"Yue B, Yang H, Wang J, Ru W, Wu J, Huang Y, Lan X, Lei C, Chen H (2020) Exosome biogenesis, secretion and function of exosomal miRNAs in skeletal muscle myogenesis. Cell Prolif 53:e12857","journal-title":"Cell Prolif"},{"key":"1050_CR30","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12943-019-0991-5","volume":"18","author":"L Mashouri","year":"2019","unstructured":"Mashouri L, Yousefi H, Aref AR, Ahadi AM, Molaei F, Alahari SK (2019) Exosomes: composition, biogenesis, and mechanisms in cancer metastasis and drug resistance. Mol Cancer 18:75","journal-title":"Mol Cancer"},{"key":"1050_CR31","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00018-017-2595-9","volume":"75","author":"NP Hessvik","year":"2018","unstructured":"Hessvik NP, Llorente A (2018) Current knowledge on exosome biogenesis and release. Cell Mol Life Sci 75:193\u2013208","journal-title":"Cell Mol Life Sci"},{"key":"1050_CR32","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12943-022-01671-0","volume":"21","author":"QF Han","year":"2022","unstructured":"Han QF, Li WJ, Hu KS, Gao J, Zhai WL, Yang JH, Zhang SJ (2022) Exosome biogenesis: machinery, regulation, and therapeutic implications in cancer. Mol Cancer 21:207","journal-title":"Mol Cancer"},{"key":"1050_CR33","doi-asserted-by":"publisher","first-page":"6917","DOI":"10.2147\/IJN.S264498","volume":"15","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Bi J, Huang J, Tang Y, Du S, Li P (2020) Exosome: a review of its classification, isolation techniques, Storage, Diagnostic and targeted therapy applications. Int J Nanomed 15:6917\u20136934","journal-title":"Int J Nanomed"},{"key":"1050_CR34","doi-asserted-by":"publisher","first-page":"e12404","DOI":"10.1002\/jev2.12404","volume":"13","author":"JA Welsh","year":"2024","unstructured":"Welsh JA, Goberdhan DCI, O\u2019Driscoll L, Buzas EI, Blenkiron C, Bussolati B, Cai H, Di Vizio D, Driedonks TAP, Erdbr\u00fcgger U et al (2024) Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches. J Extracell Vesicles 13:e12404","journal-title":"J Extracell Vesicles"},{"key":"1050_CR35","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.cell.2019.02.029","volume":"177","author":"DK Jeppesen","year":"2019","unstructured":"Jeppesen DK, Fenix AM, Franklin JL, Higginbotham JN, Zhang Q, Zimmerman LJ, Liebler DC, Ping J, Liu Q, Evans R et al (2019) Reassessment of Exosome Composition. Cell 177:428\u2013445e418","journal-title":"Cell"},{"key":"1050_CR36","doi-asserted-by":"publisher","first-page":"933736","DOI":"10.3389\/fimmu.2022.933736","volume":"13","author":"Z Zhou","year":"2022","unstructured":"Zhou Z, Wang R, Wang J, Hao Y, Xie Q, Wang L, Wang X (2022) Melatonin pretreatment on exosomes: heterogeneity, therapeutic effects, and usage. Front Immunol 13:933736","journal-title":"Front Immunol"},{"key":"1050_CR37","doi-asserted-by":"crossref","unstructured":"Valadi H, Ekstr\u00f6m K, Bossios A, Sj\u00f6strand M, Lee JJ (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. 9:654\u2013659L\u00f6tvall JOJNcb","DOI":"10.1038\/ncb1596"},{"key":"1050_CR38","doi-asserted-by":"crossref","unstructured":"Guduric-Fuchs J, O\u2019Connor A, Camp B, O\u2019Neill CL, Medina RJ (2012) Selective extracellular vesicle-mediated export of an overlapping set of microRNAs from multiple cell types. 13:1\u201314Simpson DAJBg","DOI":"10.1186\/1471-2164-13-357"},{"key":"1050_CR39","first-page":"27066","volume":"4","author":"M Y\u00e1\u00f1ez-M\u00f3","year":"2015","unstructured":"Y\u00e1\u00f1ez-M\u00f3 M, Siljander PR-M, Andreu Z, Bedina Zavec A, Borr\u00e0s FE, Buzas EI, Buzas K, Casal E, Cappello F (2015) Biological properties of extracellular vesicles and their physiological functions. Carvalho JJJoev 4:27066","journal-title":"Carvalho JJJoev"},{"key":"1050_CR40","first-page":"336","volume":"16","author":"MA Mori","year":"2012","unstructured":"Mori MA, Raghavan P, Thomou T, Boucher J, Robida-Stubbs S, Macotela Y, Russell SJ, Kirkland JL, Blackwell TK (2012) Role of microRNA processing in adipose tissue in stress defense and longevity. Kahn CRJCm 16:336\u2013347","journal-title":"Kahn CRJCm"},{"key":"1050_CR41","first-page":"1286095","volume":"6","author":"B Mateescu","year":"2017","unstructured":"Mateescu B, Kowal EJ, Van Balkom BW, Bartel S, Bhattacharyya SN, Buz\u00e1s EI, Buck AH, de Candia P, Chow FW (2017) Obstacles and opportunities in the functional analysis of extracellular vesicle RNA\u2013an ISEV position paper. Das SJJoev 6:1286095","journal-title":"Das SJJoev"},{"key":"1050_CR42","doi-asserted-by":"crossref","unstructured":"Kosaka N, Iguchi H, Yoshioka Y, Takeshita F, Matsuki Y (2010) Secretory mechanisms and intercellular transfer of microRNAs in living cells*\u2666. 285:17442\u201317452Ochiya TJJoBC","DOI":"10.1074\/jbc.M110.107821"},{"key":"1050_CR43","doi-asserted-by":"crossref","unstructured":"Santangelo L, Giurato G, Cicchini C, Montaldo C, Mancone C, Tarallo R, Battistelli C, Alonzi T, Weisz A, Tripodi MJCr (2016) & The RNA-binding protein SYNCRIP is a component of the hepatocyte exosomal machinery controlling microRNA sorting. 17:799\u2013808","DOI":"10.1016\/j.celrep.2016.09.031"},{"key":"1050_CR44","doi-asserted-by":"crossref","unstructured":"Temoche-Diaz MM, Shurtleff MJ, Nottingham RM, Yao J, Fadadu RP, Lambowitz AM, Schekman RJE (2019) Distinct mechanisms of microRNA sorting into cancer cell-derived extracellular vesicle subtypes. 8:e47544","DOI":"10.7554\/eLife.47544"},{"key":"1050_CR45","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1194\/jlr.R084343","volume":"60","author":"T Skotland","year":"2019","unstructured":"Skotland T, Hessvik NP, Sandvig K, Llorente A (2019) Exosomal lipid composition and the role of ether lipids and phosphoinositides in exosome biology. J Lipid Res 60:9\u201318","journal-title":"J Lipid Res"},{"key":"1050_CR46","doi-asserted-by":"crossref","unstructured":"Hassanzadeh A, Rahman HS, Markov A, Endjun JJ, Zekiy AO, Chartrand MS, Beheshtkhoo N, Kouhbanani MAJ, Marofi F, Nikoo, MJScr et al (2021) Mesenchymal stem\/stromal cell-derived exosomes in regenerative medicine and cancer; overview of development, challenges, and opportunities. 12:297","DOI":"10.1186\/s13287-021-02378-7"},{"key":"1050_CR47","doi-asserted-by":"publisher","first-page":"e110","DOI":"10.1002\/cpcb.110","volume":"88","author":"C Coughlan","year":"2020","unstructured":"Coughlan C, Bruce KD, Burgy O, Boyd TD, Michel CR, Garcia-Perez JE, Adame V, Anton P, Bettcher BM, Chial HJ et al (2020) Exosome isolation by Ultracentrifugation and Precipitation and techniques for downstream analyses. Curr Protocols cell Biology 88:e110","journal-title":"Curr Protocols cell Biology"},{"key":"1050_CR48","doi-asserted-by":"crossref","unstructured":"Doyle LM, Wang MZ (2019) Overview of Extracellular Vesicles, Their Origin, Composition, Purpose, and Methods for Exosome Isolation and Analysis. Cells 8","DOI":"10.3390\/cells8070727"},{"key":"1050_CR49","doi-asserted-by":"publisher","first-page":"114487","DOI":"10.1016\/j.bios.2022.114487","volume":"214","author":"L Zhao","year":"2022","unstructured":"Zhao L, Wang H, Fu J, Wu X, Liang XY, Liu XY, Wu X, Cao LL, Xu ZY, Dong M (2022) Microfluidic-based exosome isolation and highly sensitive aptamer exosome membrane protein detection for lung cancer diagnosis. Biosens Bioelectron 214:114487","journal-title":"Biosens Bioelectron"},{"key":"1050_CR50","doi-asserted-by":"crossref","unstructured":"Kang YT, Niu Z, Hadlock T, Purcell E, Lo TW, Zeinali M, Owen S, Keshamouni VG, Reddy R, Ramnath N et al (2021) On-Chip Biogenesis of Circulating NK Cell-Derived Exosomes in Non-Small Cell Lung Cancer Exhibits Antitumoral Activity. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 8:2003747","DOI":"10.1002\/advs.202003747"},{"key":"1050_CR51","doi-asserted-by":"publisher","first-page":"2732","DOI":"10.7150\/thno.18752","volume":"7","author":"L Zhu","year":"2017","unstructured":"Zhu L, Kalimuthu S, Gangadaran P, Oh JM, Lee HW, Baek SH, Jeong SY, Lee SW, Lee J, Ahn BC (2017) Exosomes Derived from Natural Killer cells exert therapeutic effect in Melanoma. Theranostics 7:2732\u20132745","journal-title":"Theranostics"},{"key":"1050_CR52","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/s41392-021-00805-y","volume":"6","author":"Y Wang","year":"2021","unstructured":"Wang Y, Li M, Chen L, Bian H, Chen X, Zheng H, Yang P, Chen Q, Xu H (2021) Natural killer cell-derived exosomal mir-1249-3p attenuates insulin resistance and inflammation in mouse models of type 2 diabetes. Signal Transduct Target Ther 6:409","journal-title":"Signal Transduct Target Ther"},{"key":"1050_CR53","first-page":"261","volume":"21","author":"MH Razizadeh","year":"2023","unstructured":"Razizadeh MH, Zafarani A, Taghavi-Farahabadi M, Khorramdelazad H, Minaeian S, Mahmoudi M (2023) Natural killer cells and their exosomes in viral infections and related therapeutic approaches: where are we? Cell communication and signaling. CCS 21:261","journal-title":"CCS"},{"key":"1050_CR54","doi-asserted-by":"publisher","first-page":"622956","DOI":"10.3389\/fonc.2020.622956","volume":"10","author":"DL Papademetrio","year":"2020","unstructured":"Papademetrio DL, Garcia MN, Grasso D, Alvarez \u00c9 (2020) Autophagy-mediated exosomes as Immunomodulators of Natural Killer cells in pancreatic Cancer Microenvironment. Front Oncol 10:622956","journal-title":"Front Oncol"},{"key":"1050_CR55","doi-asserted-by":"crossref","unstructured":"Raulet DH, Gasser S, Gowen BG, Deng W (2013) Regulation of ligands for the NKG2D activating receptor. 31:413\u2013441Jung HJAroi","DOI":"10.1146\/annurev-immunol-032712-095951"},{"key":"1050_CR56","doi-asserted-by":"crossref","unstructured":"Jong AY, Wu C-H, Li J, Sun J, Fabbri M, Wayne AS (2017) Large-scale isolation and cytotoxicity of extracellular vesicles derived from activated human natural killer cells. 6:1294368Seeger RCJJoev","DOI":"10.1080\/20013078.2017.1294368"},{"key":"1050_CR57","doi-asserted-by":"crossref","unstructured":"Zhu L, Kalimuthu S, Gangadaran P, Oh JM, Lee HW, Baek SH, Jeong SY, Lee S-W, Lee J, Ahn B-CJT (2017) Exosomes derived from natural killer cells exert therapeutic effect in melanoma. 7:2732","DOI":"10.7150\/thno.18752"},{"key":"1050_CR58","doi-asserted-by":"crossref","unstructured":"Oelsner S, Waldmann A, Billmeier A, R\u00f6der J, Lindner A, Ullrich E, Marschalek R, Dotti G, Jung G (2019) Genetically engineered CAR NK cells display selective cytotoxicity against FLT3\u2010positive B\u2010ALL and inhibit in vivo leukemia growth. 145:1935\u20131945Gro\u00dfe-Hovest LJIjoc","DOI":"10.1002\/ijc.32269"},{"key":"1050_CR59","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jconrel.2021.11.019","volume":"341","author":"H Li","year":"2022","unstructured":"Li H, Feng Y, Zheng X, Jia M, Mei Z, Wang Y, Zhang Z, Zhou M, Li C (2022) M2-type exosomes nanoparticles for rheumatoid arthritis therapy via macrophage re-polarization. J Controlled Release: Official J Controlled Release Soc 341:16\u201330","journal-title":"J Controlled Release: Official J Controlled Release Soc"},{"key":"1050_CR60","doi-asserted-by":"publisher","first-page":"121137","DOI":"10.1016\/j.biomaterials.2021.121137","volume":"278","author":"GR Gunassekaran","year":"2021","unstructured":"Gunassekaran GR, Poongkavithai Vadevoo SM, Baek MC, Lee B (2021) M1 macrophage exosomes engineered to foster M1 polarization and target the IL-4 receptor inhibit tumor growth by reprogramming tumor-associated macrophages into M1-like macrophages. Biomaterials 278:121137","journal-title":"Biomaterials"},{"key":"1050_CR61","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.canlet.2021.10.045","volume":"526","author":"K Wei","year":"2022","unstructured":"Wei K, Ma Z, Yang F, Zhao X, Jiang W, Pan C, Li Z, Pan X, He Z, Xu J et al (2022) M2 macrophage-derived exosomes promote lung adenocarcinoma progression by delivering miR-942. Cancer Lett 526:205\u2013216","journal-title":"Cancer Lett"},{"key":"1050_CR62","doi-asserted-by":"publisher","first-page":"eabb6981","DOI":"10.1126\/scitranslmed.abb6981","volume":"13","author":"S Wang","year":"2021","unstructured":"Wang S, Li F, Ye T, Wang J, Lyu C, Qing S, Ding Z, Gao X, Jia R, Yu D et al (2021) Macrophage-tumor chimeric exosomes accumulate in lymph node and tumor to activate the immune response and the tumor microenvironment. Sci Transl Med 13:eabb6981","journal-title":"Sci Transl Med"},{"key":"1050_CR63","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.actbio.2020.12.046","volume":"122","author":"Y Nakao","year":"2021","unstructured":"Nakao Y, Fukuda T, Zhang Q, Sanui T, Shinjo T, Kou X, Chen C, Liu D, Watanabe Y, Hayashi C et al (2021) Exosomes from TNF-\u03b1-treated human gingiva-derived MSCs enhance M2 macrophage polarization and inhibit periodontal bone loss. Acta Biomater 122:306\u2013324","journal-title":"Acta Biomater"},{"key":"1050_CR64","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.imlet.2020.08.003","volume":"227","author":"J Liu","year":"2020","unstructured":"Liu J, Wu F, Zhou H (2020) Macrophage-derived exosomes in cancers: Biogenesis, functions and therapeutic applications. Immunol Lett 227:102\u2013108","journal-title":"Immunol Lett"},{"key":"1050_CR65","doi-asserted-by":"crossref","unstructured":"Yang P, Peng Y, Feng Y, Xu Z, Feng P, Cao J, Chen Y, Chen X, Cao X (2021) Immune cell-derived extracellular vesicles\u2013new strategies in cancer immunotherapy. 12:771551Yang YJFii","DOI":"10.3389\/fimmu.2021.771551"},{"key":"1050_CR66","doi-asserted-by":"crossref","unstructured":"Mi X, Xu R, Hong S, Xu T, Zhang W, Liu MJMT-NA (2020) M2 macrophage-derived exosomal lncRNA AFAP1-AS1 and MicroRNA-26a affect cell migration and metastasis in esophageal cancer. 22:779\u2013790","DOI":"10.1016\/j.omtn.2020.09.035"},{"key":"1050_CR67","doi-asserted-by":"crossref","unstructured":"Goto Y, Ogawa Y, Tsumoto H, Miura Y, Nakamura TJ, Ogawa K, Akimoto Y, Kawakami H, Endo T (2018) Contribution of the exosome-associated form of secreted endoplasmic reticulum aminopeptidase 1 to exosome-mediated macrophage activation. 1865:874\u2013888Yanoshita RJBeBA-MCR","DOI":"10.1016\/j.bbamcr.2018.03.009"},{"key":"1050_CR68","doi-asserted-by":"crossref","unstructured":"Wu J, Gao W, Tang Q, Yu Y, You W, Wu Z, Fan Y, Zhang L, Wu C, Han GJH (2021) Retracted: M2 macrophage\u2013derived exosomes facilitate HCC metastasis by transferring \u03b1M\u03b22 integrin to tumor cells. 73:1365\u20131380","DOI":"10.1002\/hep.31432"},{"key":"1050_CR69","doi-asserted-by":"crossref","unstructured":"Choo YW, Kang M, Kim HY, Han J, Kang S, Lee J-R, Jeong G-J, Kwon SP, Song SY (2018) M1 macrophage-derived nanovesicles potentiate the anticancer efficacy of immune checkpoint inhibitors. 12:8977\u20138993Go SJAn","DOI":"10.1021\/acsnano.8b02446"},{"key":"1050_CR70","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s13045-020-00939-6","volume":"13","author":"Y Wang","year":"2020","unstructured":"Wang Y, Xiang Y, Xin VW, Wang XW, Peng XC, Liu XQ, Wang D, Li N, Cheng JT, Lyv YN et al (2020) Dendritic cell biology and its role in tumor immunotherapy. J Hematol Oncol 13:107","journal-title":"J Hematol Oncol"},{"key":"1050_CR71","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1172\/JCI81137","volume":"126","author":"JM Pitt","year":"2016","unstructured":"Pitt JM, Andr\u00e9 F, Amigorena S, Soria JC, Eggermont A, Kroemer G, Zitvogel L (2016) Dendritic cell-derived exosomes for cancer therapy. J Clin Invest 126:1224\u20131232","journal-title":"J Clin Invest"},{"key":"1050_CR72","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.jconrel.2022.11.053","volume":"353","author":"J Li","year":"2023","unstructured":"Li J, Li J, Peng Y, Du Y, Yang Z, Qi X (2023) Dendritic cell derived exosomes loaded neoantigens for personalized cancer immunotherapies. J Controlled Release: Official J Controlled Release Soc 353:423\u2013433","journal-title":"J Controlled Release: Official J Controlled Release Soc"},{"key":"1050_CR73","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12943-022-01515-x","volume":"21","author":"L Huang","year":"2022","unstructured":"Huang L, Rong Y, Tang X, Yi K, Qi P, Hou J, Liu W, He Y, Gao X, Yuan C et al (2022) Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancer. Mol Cancer 21:45","journal-title":"Mol Cancer"},{"key":"1050_CR74","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1111\/jcmm.12923","volume":"20","author":"W Gao","year":"2016","unstructured":"Gao W, Liu H, Yuan J, Wu C, Huang D, Ma Y, Zhu J, Ma L, Guo J, Shi H et al (2016) Exosomes derived from mature dendritic cells increase endothelial inflammation and atherosclerosis via membrane TNF-\u03b1 mediated NF-\u03baB pathway. J Cell Mol Med 20:2318\u20132327","journal-title":"J Cell Mol Med"},{"key":"1050_CR75","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nbt.1807","volume":"29","author":"L Alvarez-Erviti","year":"2011","unstructured":"Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, Wood MJ (2011) Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol 29:341\u2013345","journal-title":"Nat Biotechnol"},{"key":"1050_CR76","first-page":"756","volume":"119","author":"A Montecalvo","year":"2012","unstructured":"Montecalvo A, Larregina AT, Shufesky WJ, Beer Stolz D, Sullivan ML, Karlsson JM, Baty CJ, Gibson GA, Erdos G, Wang ZJB (2012) Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes. J Am Soc Hematol 119:756\u2013766","journal-title":"J Am Soc Hematol"},{"key":"1050_CR77","doi-asserted-by":"crossref","unstructured":"Ji Q, Liu J, Dong Y, Wang L, Dong K, Setiz B, Szentm\u00e1ry N, Qu B (2021) Exosomes derived from thymic stromal lymphopoietin-treated dendritic cells regulate T helper 17\/regulatory T cell differentiation via miR-21\/Smad7 axis. 398:112393Shi LJEcr","DOI":"10.1016\/j.yexcr.2020.112393"},{"key":"1050_CR78","doi-asserted-by":"crossref","unstructured":"Cao Z, Wu Y, Yu L, Zou L, Yang L, Lin S, Wang J, Yuan Z, Dai JJMM (2021) Exosomal miR-335 derived from mature dendritic cells enhanced mesenchymal stem cell-mediated bone regeneration of bone defects in athymic rats. 27:1\u201313","DOI":"10.1186\/s10020-021-00268-5"},{"key":"1050_CR79","doi-asserted-by":"crossref","unstructured":"Santos P, Almeida FJF (2021) Exosome-based vaccines: history, current state, and clinical trials. 12:711565","DOI":"10.3389\/fimmu.2021.711565"},{"key":"1050_CR80","first-page":"1332","volume":"33","author":"X Zhao","year":"2021","unstructured":"Zhao X, Wang J, He J, Tian X, Zhu D, Wang J, Cai L (2021) [Effects of activated CD4(+) T cell-derived exosomes on cardiac remodeling after myocardial infarction]. Zhonghua Wei Zhong Bing Ji jiu Yi Xue 33:1332\u20131336","journal-title":"Zhonghua Wei Zhong Bing Ji jiu Yi Xue"},{"key":"1050_CR81","doi-asserted-by":"crossref","unstructured":"Wangriatisak K, Kochayoo P, Thawornpan P, Leepiyasakulchai C, Suangtamai T, Ngamjanyaporn P, Khowawisetsut L, Khaenam P, Pisitkun P, Chootong P (2022) CD4(+) T-cell cooperation promoted pathogenic function of activated na\u00efve B cells of patients with SLE. Lupus science & medicine 9","DOI":"10.1136\/lupus-2022-000739"},{"key":"1050_CR82","doi-asserted-by":"publisher","first-page":"121765","DOI":"10.1016\/j.biomaterials.2022.121765","volume":"289","author":"S Shin","year":"2022","unstructured":"Shin S, Jung I, Jung D, Kim CS, Kang SM, Ryu S, Choi SJ, Noh S, Jeong J, Lee BY et al (2022) Novel antitumor therapeutic strategy using CD4(+) T cell-derived extracellular vesicles. Biomaterials 289:121765","journal-title":"Biomaterials"},{"key":"1050_CR83","doi-asserted-by":"crossref","unstructured":"Shao Y, Pan X, Fu R (2021) Role and Function of T Cell-Derived Exosomes and Their Therapeutic Value. Mediators Inflamm 2021:8481013","DOI":"10.1155\/2021\/8481013"},{"key":"1050_CR84","doi-asserted-by":"crossref","unstructured":"Ni H, Zhang H, Li L, Huang H, Guo H, Zhang L, Li C, Xu JX, Nie CP, Li K et al (2022) T cell-intrinsic STING signaling promotes regulatory T cell induction and immunosuppression by upregulating FOXP3 transcription in cervical cancer. J Immunother Cancer 10","DOI":"10.1136\/jitc-2022-005151"},{"key":"1050_CR85","doi-asserted-by":"publisher","first-page":"110560","DOI":"10.1016\/j.intimp.2023.110560","volume":"122","author":"L Huang","year":"2023","unstructured":"Huang L, Liang L, Ji Z, Chen S, Liu M, Huang Q, Huang Z, Sun S, Ding J, Chen J et al (2023) Proteomics profiling of CD4\u2009+\u2009T-cell-derived exosomes from patients with rheumatoid arthritis. Int Immunopharmacol 122:110560","journal-title":"Int Immunopharmacol"},{"key":"1050_CR86","doi-asserted-by":"publisher","first-page":"753884","DOI":"10.3389\/fcell.2021.753884","volume":"9","author":"D Di Silvestre","year":"2021","unstructured":"Di Silvestre D, Garavelli S, Procaccini C, Prattichizzo F, Passignani G, De Rosa V, Mauri P, Matarese G, de Candia P (2021) CD4(+) T-Cell activation prompts suppressive function by Extracellular Vesicle-Associated MicroRNAs. Front cell Dev Biology 9:753884","journal-title":"Front cell Dev Biology"},{"key":"1050_CR87","doi-asserted-by":"publisher","first-page":"9037","DOI":"10.1007\/s11033-023-08767-w","volume":"50","author":"Z Bolandi","year":"2023","unstructured":"Bolandi Z, Hashemi SM, Abasi M, Musavi M, Aghamiri S, Miyanmahaleh N, Ghanbarian H (2023) In vitro naive CD4(+) T cell differentiation upon treatment with miR-29b-loaded exosomes from mesenchymal stem cells. Mol Biol Rep 50:9037\u20139046","journal-title":"Mol Biol Rep"},{"key":"1050_CR88","doi-asserted-by":"crossref","unstructured":"Lin C, Guo J, Jia R (2022) Roles of Regulatory T Cell-Derived Extracellular vesicles in Human diseases. Int J Mol Sci 23","DOI":"10.3390\/ijms231911206"},{"key":"1050_CR89","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.immuni.2014.05.019","volume":"41","author":"IS Okoye","year":"2014","unstructured":"Okoye IS, Coomes SM, Pelly VS, Czieso S, Papayannopoulos V, Tolmachova T, Seabra MC, Wilson MS (2014) MicroRNA-containing T-regulatory-cell-derived exosomes suppress pathogenic T helper 1 cells. Immunity 41:89\u2013103","journal-title":"Immunity"},{"key":"1050_CR90","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3390\/cells8020154","volume":"8","author":"A Anel","year":"2019","unstructured":"Anel A, Gallego-Lleyda A, de Miguel D, Naval J, Mart\u00ednez-Lostao L (2019) Role of exosomes in the regulation of T-cell mediated immune responses and in autoimmune disease. Cells 8:154","journal-title":"Cells"},{"key":"1050_CR91","doi-asserted-by":"crossref","unstructured":"Wang X, Shen H, He Q, Tian W, Xia A, Lu X-J (2018) Exosomes derived from exhausted CD8\u2009+\u2009T cells impaired the anticancer function of normal CD8\u2009+\u2009T cells. Journal of Medical Genetics","DOI":"10.1136\/jmedgenet-2018-105439"},{"key":"1050_CR92","doi-asserted-by":"publisher","first-page":"4992","DOI":"10.1038\/s41388-021-01896-1","volume":"40","author":"Y Qiu","year":"2021","unstructured":"Qiu Y, Yang Y, Yang R, Liu C, Hsu J-M, Jiang Z, Sun L, Wei Y, Li C-W, Yu D (2021) Activated T cell-derived exosomal PD-1 attenuates PD-L1-induced immune dysfunction in triple-negative breast cancer. Oncogene 40:4992\u20135001","journal-title":"Oncogene"},{"key":"1050_CR93","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1136\/jmedgenet-2018-105439","volume":"56","author":"X Wang","year":"2019","unstructured":"Wang X, Shen H, He Q, Tian W, Xia A, Lu XJ (2019) Exosomes derived from exhausted CD8\u2009+\u2009T cells impaired the anticancer function of normal CD8\u2009+\u2009T cells. J Med Genet 56:29\u201331","journal-title":"J Med Genet"},{"key":"1050_CR94","doi-asserted-by":"crossref","unstructured":"Cai Z, Yang F, Yu L, Yu Z, Jiang L, Wang Q, Yang Y, Wang L, Cao X, Wang J (2012) Activated T cell exosomes promote tumor invasion via Fas signaling pathway. Journal of immunology (Baltimore, Md: 1950) 188:5954\u20135961","DOI":"10.4049\/jimmunol.1103466"},{"key":"1050_CR95","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s12253-016-0185-z","volume":"24","author":"H Min","year":"2018","unstructured":"Min H, Sun X, Yang X, Zhu H, Liu J, Wang Y, Chen G, Sun X (2018) Exosomes derived from irradiated esophageal carcinoma-infiltrating T cells promote metastasis by inducing the epithelial\u2013mesenchymal transition in esophageal cancer cells. Pathol Oncol Res 24:11\u201318","journal-title":"Pathol Oncol Res"},{"key":"1050_CR96","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.jconrel.2023.10.007","volume":"363","author":"B Tao","year":"2023","unstructured":"Tao B, Du R, Zhang X, Jia B, Gao Y, Zhao Y, Liu Y (2023) Engineering CAR-NK cell derived exosome disguised nano-bombs for enhanced HER2 positive breast cancer brain metastasis therapy. J Controlled Release: Official J Controlled Release Soc 363:692\u2013706","journal-title":"J Controlled Release: Official J Controlled Release Soc"},{"key":"1050_CR97","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1007\/s12185-022-03436-3","volume":"117","author":"T Yamamoto","year":"2023","unstructured":"Yamamoto T, Yamamoto Y, Ochiya T (2023) Extracellular vesicle-mediated immunoregulation in cancer. Int J Hematol 117:640\u2013646","journal-title":"Int J Hematol"},{"key":"1050_CR98","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.1158\/0008-5472.CAN-22-2220","volume":"83","author":"W Zhong","year":"2023","unstructured":"Zhong W, Xiao Z, Qin Z, Yang J, Wen Y, Yu Z, Li Y, Sheppard NC, Fuchs SY, Xu X et al (2023) Tumor-derived small extracellular vesicles inhibit the efficacy of CAR T cells against solid tumors. Cancer Res 83:2790\u20132806","journal-title":"Cancer Res"},{"key":"1050_CR99","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13287-024-03783-4","volume":"15","author":"F Sani","year":"2024","unstructured":"Sani F, Shojaei S, Tabatabaei SA, Khorraminejad-Shirazi M, Latifi M, Sani M, Azarpira N (2024) CAR-T cell-derived exosomes: a new perspective for cancer therapy. Stem Cell Res Ther 15:174","journal-title":"Stem Cell Res Ther"},{"key":"1050_CR100","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.jcyt.2023.01.005","volume":"25","author":"K Si","year":"2023","unstructured":"Si K, Dai Z, Li Z, Ye Z, Ding B, Feng S, Sun B, Shen Y, Xiao Z (2023) Engineered exosome-mediated messenger RNA and single-chain variable fragment delivery for human chimeric antigen receptor T-cell engineering. Cytotherapy 25:615\u2013624","journal-title":"Cytotherapy"},{"key":"1050_CR101","doi-asserted-by":"publisher","first-page":"1385571","DOI":"10.3389\/fimmu.2024.1385571","volume":"15","author":"Z Niu","year":"2024","unstructured":"Niu Z, Wu J, Zhao Q, Zhang J, Zhang P, Yang Y (2024) CAR-based immunotherapy for breast cancer: peculiarities, ongoing investigations, and future strategies. Front Immunol 15:1385571","journal-title":"Front Immunol"},{"key":"1050_CR102","doi-asserted-by":"crossref","unstructured":"Fu W, Lei C, Liu S, Cui Y, Wang C, Qian K, Li T, Shen Y, Fan X (2019) CAR exosomes derived from effector CAR-T cells have potent antitumour effects and low toxicity. 10:4355Lin FJNc","DOI":"10.1038\/s41467-019-12321-3"},{"key":"1050_CR103","doi-asserted-by":"crossref","unstructured":"Yang P, Cao X, Cai H, Feng P, Chen X, Zhu Y, Yang Y, An W, Yang Y (2021) The exosomes derived from CAR-T cell efficiently target mesothelin and reduce triple-negative breast cancer growth. 360:104262Jie JJCi","DOI":"10.1016\/j.cellimm.2020.104262"},{"key":"1050_CR104","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.molmed.2019.02.003","volume":"25","author":"RE Veerman","year":"2019","unstructured":"Veerman RE, G\u00fc\u00e7l\u00fcler Akpinar G, Eldh M, Gabrielsson S (2019) Immune Cell-Derived Extracellular vesicles - functions and therapeutic applications. Trends Mol Med 25:382\u2013394","journal-title":"Trends Mol Med"},{"key":"1050_CR105","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s13402-017-0334-8","volume":"40","author":"M Sromek","year":"2017","unstructured":"Sromek M, Glogowski M, Chechlinska M, Kulinczak M, Szafron L, Zakrzewska K, Owczarek J, Wisniewski P, Wlodarczyk R, Talarek L et al (2017) Changes in plasma miR-9, miR-16, miR-205 and miR-486 levels after non-small cell lung cancer resection. Cell Oncol (Dordr) 40:529\u2013536","journal-title":"Cell Oncol (Dordr)"},{"key":"1050_CR106","first-page":"446","volume":"67","author":"A Usmani","year":"2017","unstructured":"Usmani A, Shoro AA, Shirazi B, Memon Z, Hussain M (2017) MiR-16: a novel hereditary marker in breast cancer and their offspring. J Pak Med Assoc 67:446\u2013450","journal-title":"J Pak Med Assoc"},{"key":"1050_CR107","first-page":"53","volume":"2","author":"KM Ilkhomovna","year":"2020","unstructured":"Ilkhomovna KM, Eriyigitovich IS, Kadyrovich KN (2020) Morphological features of microvascular tissue of the brain at hemorrhagic stroke. Am J Med Sci Pharm Res 2:53\u201359","journal-title":"Am J Med Sci Pharm Res"},{"key":"1050_CR108","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nri2073","volume":"7","author":"HG Ljunggren","year":"2007","unstructured":"Ljunggren HG, Malmberg KJ (2007) Prospects for the use of NK cells in immunotherapy of human cancer. Nat Rev Immunol 7:329\u2013339","journal-title":"Nat Rev Immunol"},{"key":"1050_CR109","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.3389\/fimmu.2019.02819","volume":"10","author":"H Sun","year":"2019","unstructured":"Sun H, Shi K, Qi K, Kong H, Zhang J, Dai S, Ye W, Deng T, He Q, Zhou M (2019) Natural killer cell-derived exosomal mir-3607-3p inhibits pancreatic Cancer progression by targeting IL-26. Front Immunol 10:2819","journal-title":"Front Immunol"},{"key":"1050_CR110","first-page":"2859","volume":"4","author":"Y Yan","year":"1998","unstructured":"Yan Y, Steinherz P, Klingemann HG, Dennig D, Childs BH, McGuirk J, O\u2019Reilly RJ (1998) Antileukemia activity of a natural killer cell line against human leukemias. Clin Cancer Res 4:2859\u20132868","journal-title":"Clin Cancer Res"},{"key":"1050_CR111","doi-asserted-by":"publisher","first-page":"1087689","DOI":"10.3389\/fimmu.2022.1087689","volume":"13","author":"H Luo","year":"2022","unstructured":"Luo H, Zhou Y, Zhang J, Zhang Y, Long S, Lin X, Yang A, Duan J, Yang N, Yang Z et al (2022) NK cell-derived exosomes enhance the anti-tumor effects against ovarian cancer by delivering cisplatin and reactivating NK cell functions. Front Immunol 13:1087689","journal-title":"Front Immunol"},{"key":"1050_CR112","doi-asserted-by":"publisher","first-page":"1588538","DOI":"10.1080\/20013078.2019.1588538","volume":"8","author":"CH Wu","year":"2019","unstructured":"Wu CH, Li J, Li L, Sun J, Fabbri M, Wayne AS, Seeger RC, Jong AY (2019) Extracellular vesicles derived from natural killer cells use multiple cytotoxic proteins and killing mechanisms to target cancer cells. J Extracell Vesicles 8:1588538","journal-title":"J Extracell Vesicles"},{"key":"1050_CR113","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.4049\/jimmunol.1101988","volume":"189","author":"L Lugini","year":"2012","unstructured":"Lugini L, Cecchetti S, Huber V, Luciani F, Macchia G, Spadaro F, Paris L, Abalsamo L, Colone M, Molinari A et al (2012) Immune Surveillance Properties of Human NK Cell-Derived exosomes. J Immunol 189:2833\u20132842","journal-title":"J Immunol"},{"key":"1050_CR114","doi-asserted-by":"publisher","first-page":"661","DOI":"10.3390\/cancers12030661","volume":"12","author":"AL Di Pace","year":"2020","unstructured":"Di Pace AL, Tumino N, Besi F, Alicata C, Conti LA, Munari E, Maggi E, Vacca P, Moretta L (2020) Characterization of Human NK Cell-Derived exosomes: role of DNAM1 receptor in exosome-mediated cytotoxicity against Tumor. Cancers 12:661","journal-title":"Cancers"},{"key":"1050_CR115","doi-asserted-by":"publisher","first-page":"2221081","DOI":"10.1080\/2162402X.2023.2221081","volume":"12","author":"AL Di Pace","year":"2023","unstructured":"Di Pace AL, Pelosi A, Fiore PF, Tumino N, Besi F, Quatrini L, Santopolo S, Vacca P, Moretta L (2023) MicroRNA analysis of natural killer cell-derived exosomes: the microRNA let-7b-5p is enriched in exosomes and participates in their anti-tumor effects against pancreatic cancer cells. Oncoimmunology 12:2221081","journal-title":"Oncoimmunology"},{"key":"1050_CR116","doi-asserted-by":"publisher","first-page":"a014415","DOI":"10.1101\/cshperspect.a014415","volume":"3","author":"M Huang","year":"2013","unstructured":"Huang M, Weiss WA (2013) Neuroblastoma and MYCN. Cold Spring Harb Perspect Med 3:a014415","journal-title":"Cold Spring Harb Perspect Med"},{"key":"1050_CR117","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1158\/0008-5472.CAN-18-0779","volume":"79","author":"P Neviani","year":"2019","unstructured":"Neviani P, Wise PM, Murtadha M, Liu CW, Wu CH, Jong AY, Seeger RC, Fabbri M (2019) Natural killer-derived exosomal miR-186 inhibits Neuroblastoma Growth and Immune escape mechanisms. Cancer Res 79:1151\u20131164","journal-title":"Cancer Res"},{"key":"1050_CR118","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1158\/2326-6066.CIR-17-0479","volume":"6","author":"J Zhou","year":"2018","unstructured":"Zhou J, Li X, Wu X, Zhang T, Zhu Q, Wang X, Wang H, Wang K, Lin Y, Wang X (2018) Exosomes released from Tumor-Associated macrophages transfer miRNAs that induce a Treg\/Th17 Cell Imbalance in Epithelial Ovarian Cancer. Cancer Immunol Res 6:1578\u20131592","journal-title":"Cancer Immunol Res"},{"key":"1050_CR119","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s10020-020-00207-w","volume":"26","author":"L Wang","year":"2020","unstructured":"Wang L, Wang Y, Quan J (2020) Exosomal miR-223 derived from natural killer cells inhibits hepatic stellate cell activation by suppressing autophagy. Mol Med 26:81","journal-title":"Mol Med"},{"key":"1050_CR120","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/gcc.22334","volume":"55","author":"S Avigad","year":"2016","unstructured":"Avigad S, Verly IR, Lebel A, Kordi O, Shichrur K, Ohali A, Hameiri-Grossman M, Kaspers GJ, Cloos J, Fronkova E et al (2016) miR expression profiling at diagnosis predicts relapse in pediatric precursor B-cell acute lymphoblastic leukemia. Genes Chromosomes Cancer 55:328\u2013339","journal-title":"Genes Chromosomes Cancer"},{"key":"1050_CR121","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/onc.2011.223","volume":"31","author":"A Bergamaschi","year":"2012","unstructured":"Bergamaschi A, Katzenellenbogen BS (2012) Tamoxifen downregulation of miR-451 increases 14-3-3\u03b6 and promotes breast cancer cell survival and endocrine resistance. Oncogene 31:39\u201347","journal-title":"Oncogene"},{"key":"1050_CR122","doi-asserted-by":"publisher","first-page":"1060000","DOI":"10.3389\/fcell.2023.1060000","volume":"11","author":"OE Musatova","year":"2023","unstructured":"Musatova OE, Rubtsov YP (2023) Effects of glioblastoma-derived extracellular vesicles on the functions of immune cells. Front Cell Dev Biol 11:1060000","journal-title":"Front Cell Dev Biol"},{"key":"1050_CR123","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.1038\/onc.2010.642","volume":"30","author":"R Wang","year":"2011","unstructured":"Wang R, Wang ZX, Yang JS, Pan X, De W, Chen LB (2011) MicroRNA-451 functions as a tumor suppressor in human non-small cell lung cancer by targeting ras-related protein 14 (RAB14). Oncogene 30:2644\u20132658","journal-title":"Oncogene"},{"key":"1050_CR124","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1158\/1078-0432.CCR-08-1818","volume":"15","author":"E Bandres","year":"2009","unstructured":"Bandres E, Bitarte N, Arias F, Agorreta J, Fortes P, Agirre X, Zarate R, Diaz-Gonzalez JA, Ramirez N, Sola JJ et al (2009) microRNA-451 regulates Macrophage Migration Inhibitory factor production and proliferation of gastrointestinal Cancer cells. Clin Cancer Res 15:2281\u20132290","journal-title":"Clin Cancer Res"},{"key":"1050_CR125","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/cas.13429","volume":"109","author":"F Liu","year":"2018","unstructured":"Liu F, Bu Z, Zhao F, Xiao D (2018) Increased T-helper 17 cell differentiation mediated by exosome-mediated microRNA-451 redistribution in gastric cancer infiltrated T cells. Cancer Sci 109:65\u201373","journal-title":"Cancer Sci"},{"key":"1050_CR126","doi-asserted-by":"publisher","first-page":"e1027472","DOI":"10.1080\/2162402X.2015.1027472","volume":"4","author":"Y Liu","year":"2015","unstructured":"Liu Y, Gu Y, Cao X (2015) The exosomes in tumor immunity. Oncoimmunology 4:e1027472","journal-title":"Oncoimmunology"},{"key":"1050_CR127","doi-asserted-by":"crossref","unstructured":"Thyagarajan A, Alshehri MSA, Miller KLR, Sherwin CM, Travers JB, Sahu RP (2019) Myeloid-Derived Suppressor Cells and Pancreatic Cancer: Implications in Novel Therapeutic Approaches. Cancers (Basel) 11","DOI":"10.3390\/cancers11111627"},{"key":"1050_CR128","doi-asserted-by":"publisher","first-page":"43992","DOI":"10.18632\/oncotarget.6083","volume":"6","author":"J Wang","year":"2015","unstructured":"Wang J, De Veirman K, De Beule N, Maes K, De Bruyne E, Van Valckenborgh E, Vanderkerken K, Menu E (2015) The bone marrow microenvironment enhances multiple myeloma progression by exosome-mediated activation of myeloid-derived suppressor cells. Oncotarget 6:43992\u201344004","journal-title":"Oncotarget"},{"key":"1050_CR129","doi-asserted-by":"crossref","unstructured":"Whiteside TL (2016) Tumor-derived exosomes and their role in Tumor-Induced Immune suppression. Vaccines (Basel) 4","DOI":"10.3390\/vaccines4040035"},{"key":"1050_CR130","doi-asserted-by":"publisher","first-page":"4023","DOI":"10.2147\/CMAR.S198886","volume":"11","author":"W Ren","year":"2019","unstructured":"Ren W, Zhang X, Li W, Feng Q, Feng H, Tong Y, Rong H, Wang W, Zhang D, Zhang Z et al (2019) Exosomal miRNA-107 induces myeloid-derived suppressor cell expansion in gastric cancer. Cancer Manag Res 11:4023\u20134040","journal-title":"Cancer Manag Res"},{"key":"1050_CR131","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1515\/hsz-2018-0002","volume":"399","author":"LL Zhang","year":"2018","unstructured":"Zhang LL, Zhang LF, Shi YB (2018) Down-regulated paxillin suppresses cell proliferation and invasion by inhibiting M2 macrophage polarization in colon cancer. Biol Chem 399:1285\u20131295","journal-title":"Biol Chem"},{"key":"1050_CR132","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.omto.2021.02.005","volume":"20","author":"YS Ma","year":"2021","unstructured":"Ma YS, Wu TM, Ling CC, Yu F, Zhang J, Cao PS, Gu LP, Wang HM, Xu H, Li L et al (2021) M2 macrophage-derived exosomal microRNA-155-5p promotes the immune escape of colon cancer by downregulating ZC3H12B. Mol Ther Oncolytics 20:484\u2013498","journal-title":"Mol Ther Oncolytics"},{"key":"1050_CR133","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s00005-013-0231-4","volume":"61","author":"A Matejuk","year":"2013","unstructured":"Matejuk A, Collet G, Nadim M, Grillon C, Kieda C (2013) MicroRNAs and tumor vasculature normalization: impact on anti-tumor immune response. Arch Immunol Ther Exp (Warsz) 61:285\u2013299","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"1050_CR134","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1002\/cncr.31062","volume":"124","author":"J Zhang","year":"2018","unstructured":"Zhang J, Raju GS, Chang DW, Lin SH, Chen Z, Wu X (2018) Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer. Cancer 124:785\u2013796","journal-title":"Cancer"},{"key":"1050_CR135","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41420-022-00919-4","volume":"8","author":"W Sun","year":"2022","unstructured":"Sun W, Cui J, Ge Y, Wang J, Yu Y, Han B, Liu B (2022) Tumor stem cell-derived exosomal microRNA-17-5p inhibits anti-tumor immunity in colorectal cancer via targeting SPOP and overexpressing PD-L1. Cell Death Discov 8:223","journal-title":"Cell Death Discov"},{"key":"1050_CR136","doi-asserted-by":"publisher","first-page":"12293","DOI":"10.1073\/pnas.192461099","volume":"99","author":"Y Iwai","year":"2002","unstructured":"Iwai Y, Ishida M, Tanaka Y, Okazaki T, Honjo T, Minato N (2002) Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade. Proc Natl Acad Sci U S A 99:12293\u201312297","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1050_CR137","doi-asserted-by":"publisher","first-page":"15894","DOI":"10.18632\/oncotarget.15213","volume":"8","author":"V Audrito","year":"2017","unstructured":"Audrito V, Serra S, Stingi A, Orso F, Gaudino F, Bologna C, Neri F, Garaffo G, Nassini R, Baroni G et al (2017) PD-L1 up-regulation in melanoma increases disease aggressiveness and is mediated through miR-17-5p. Oncotarget 8:15894\u201315911","journal-title":"Oncotarget"},{"key":"1050_CR138","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1158\/1078-0432.CCR-07-1731","volume":"14","author":"EJ Nam","year":"2008","unstructured":"Nam EJ, Yoon H, Kim SW, Kim H, Kim YT, Kim JH, Kim JW, Kim S (2008) MicroRNA expression profiles in serous ovarian carcinoma. Clin Cancer Res 14:2690\u20132695","journal-title":"Clin Cancer Res"},{"key":"1050_CR139","doi-asserted-by":"publisher","first-page":"e5311","DOI":"10.1371\/journal.pone.0005311","volume":"4","author":"SK Wyman","year":"2009","unstructured":"Wyman SK, Parkin RK, Mitchell PS, Fritz BR, O\u2019Briant K, Godwin AK, Urban N, Drescher CW, Knudsen BS, Tewari M (2009) Repertoire of microRNAs in epithelial ovarian cancer as determined by next generation sequencing of small RNA cDNA libraries. PLoS ONE 4:e5311","journal-title":"PLoS ONE"},{"key":"1050_CR140","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/cmi.2014.30","volume":"11","author":"J Xie","year":"2014","unstructured":"Xie J, Liu M, Li Y, Nie Y, Mi Q, Zhao S (2014) Ovarian tumor-associated microRNA-20a decreases natural killer cell cytotoxicity by downregulating MICA\/B expression. Cell Mol Immunol 11:495\u2013502","journal-title":"Cell Mol Immunol"},{"key":"1050_CR141","doi-asserted-by":"publisher","first-page":"622263","DOI":"10.3389\/fonc.2021.622263","volume":"11","author":"HY Zhang","year":"2021","unstructured":"Zhang HY, Liang HX, Wu SH, Jiang HQ, Wang Q, Yu ZJ (2021) Overexpressed tumor suppressor exosomal miR-15a-5p in Cancer cells inhibits PD1 expression in CD8\u2009+\u2009T cells and suppresses the Hepatocellular Carcinoma Progression. Front Oncol 11:622263","journal-title":"Front Oncol"},{"key":"1050_CR142","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1016\/j.ymthe.2020.12.034","volume":"29","author":"C Zhou","year":"2021","unstructured":"Zhou C, Wei W, Ma J, Yang Y, Liang L, Zhang Y, Wang Z, Chen X, Huang L, Wang W et al (2021) Cancer-secreted exosomal mir-1468-5p promotes tumor immune escape via the immunosuppressive reprogramming of lymphatic vessels. Mol Therapy: J Am Soc Gene Therapy 29:1512\u20131528","journal-title":"Mol Therapy: J Am Soc Gene Therapy"},{"key":"1050_CR143","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/35100529","volume":"1","author":"R Medzhitov","year":"2001","unstructured":"Medzhitov R (2001) Toll-like receptors and innate immunity. Nat Rev Immunol 1:135\u2013145","journal-title":"Nat Rev Immunol"},{"key":"1050_CR144","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.cellimm.2014.09.004","volume":"292","author":"M Zhou","year":"2014","unstructured":"Zhou M, Chen J, Zhou L, Chen W, Ding G, Cao L (2014) Pancreatic cancer derived exosomes regulate the expression of TLR4 in dendritic cells via miR-203. Cell Immunol 292:65\u201369","journal-title":"Cell Immunol"},{"key":"1050_CR145","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/sj.onc.1210904","volume":"27","author":"B Huang","year":"2008","unstructured":"Huang B, Zhao J, Unkeless JC, Feng ZH, Xiong H (2008) TLR signaling by tumor and immune cells: a double-edged sword. Oncogene 27:218\u2013224","journal-title":"Oncogene"},{"key":"1050_CR146","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/nri1391","volume":"4","author":"S Akira","year":"2004","unstructured":"Akira S, Takeda K (2004) Toll-like receptor signalling. Nat Rev Immunol 4:499\u2013511","journal-title":"Nat Rev Immunol"},{"key":"1050_CR147","doi-asserted-by":"publisher","first-page":"29877","DOI":"10.18632\/oncotarget.4924","volume":"6","author":"G Ding","year":"2015","unstructured":"Ding G, Zhou L, Qian Y, Fu M, Chen J, Chen J, Xiang J, Wu Z, Jiang G, Cao L (2015) Pancreatic cancer-derived exosomes transfer miRNAs to dendritic cells and inhibit RFXAP expression via miR-212-3p. Oncotarget 6:29877\u201329888","journal-title":"Oncotarget"},{"key":"1050_CR148","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.ccell.2019.02.008","volume":"35","author":"W Liao","year":"2019","unstructured":"Liao W, Overman MJ, Boutin AT, Shang X, Zhao D, Dey P, Li J, Wang G, Lan Z, Li J et al (2019) KRAS-IRF2 Axis drives Immune suppression and Immune Therapy Resistance in Colorectal Cancer. Cancer Cell 35:559\u2013572e557","journal-title":"Cancer Cell"},{"key":"1050_CR149","doi-asserted-by":"publisher","first-page":"e1462878","DOI":"10.1080\/2162402X.2018.1462878","volume":"7","author":"N Bordry","year":"2018","unstructured":"Bordry N, Broggi MAS, de Jonge K, Schaeuble K, Gannon PO, Foukas PG, Danenberg E, Romano E, Baumgaertner P, Fankhauser M et al (2018) Lymphatic vessel density is associated with CD8(+) T cell infiltration and immunosuppressive factors in human melanoma. Oncoimmunology 7:e1462878","journal-title":"Oncoimmunology"},{"key":"1050_CR150","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.ccr.2014.03.021","volume":"25","author":"S Su","year":"2014","unstructured":"Su S, Liu Q, Chen J, Chen J, Chen F, He C, Huang D, Wu W, Lin L, Huang W et al (2014) A positive feedback loop between mesenchymal-like cancer cells and macrophages is essential to breast cancer metastasis. Cancer Cell 25:605\u2013620","journal-title":"Cancer Cell"},{"key":"1050_CR151","doi-asserted-by":"publisher","first-page":"522","DOI":"10.3892\/or.2017.5697","volume":"38","author":"X Chen","year":"2017","unstructured":"Chen X, Ying X, Wang X, Wu X, Zhu Q, Wang X (2017) Exosomes derived from hypoxic epithelial ovarian cancer deliver microRNA-940 to induce macrophage M2 polarization. Oncol Rep 38:522\u2013528","journal-title":"Oncol Rep"},{"key":"1050_CR152","doi-asserted-by":"crossref","unstructured":"Gebeyehu A, Kommineni N, Meckes DG Jr, Singh MS (2021) Role of exosomes for delivery of chemotherapeutic drugs. Crit Reviews\u2122 Therapeutic Drug Carrier Syst 38","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2021036301"},{"key":"1050_CR153","doi-asserted-by":"publisher","first-page":"7698","DOI":"10.1021\/nn402232g","volume":"7","author":"SC Jang","year":"2013","unstructured":"Jang SC, Kim OY, Yoon CM, Choi D-S, Roh T-Y, Park J, Nilsson J, Lotvall J, Kim Y-K, Gho YS (2013) Bioinspired exosome-mimetic nanovesicles for targeted delivery of chemotherapeutics to malignant tumors. ACS Nano 7:7698\u20137710","journal-title":"ACS Nano"},{"key":"1050_CR154","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.2217\/nnm-2016-0154","volume":"11","author":"M Hadla","year":"2016","unstructured":"Hadla M, Palazzolo S, Corona G, Caligiuri I, Canzonieri V, Toffoli G, Rizzolio F (2016) Exosomes increase the therapeutic index of doxorubicin in breast and ovarian cancer mouse models. Nanomedicine: Nanatechnol Biology Med 11:2431\u20132441","journal-title":"Nanomedicine: Nanatechnol Biology Med"},{"key":"1050_CR155","doi-asserted-by":"crossref","unstructured":"Wei H, Chen F, Chen J, Lin H, Wang S, Wang Y, Wu C, Lin J, Zhong G (2022) Mesenchymal stem cell derived exosomes as nanodrug carrier of doxorubicin for targeted osteosarcoma therapy via SDF1-CXCR4 axis. Int J Nanomed :3483\u20133495","DOI":"10.2147\/IJN.S372851"},{"key":"1050_CR156","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s40199-019-00280-5","volume":"27","author":"S Salarpour","year":"2019","unstructured":"Salarpour S, Forootanfar H, Pournamdari M, Ahmadi-Zeidabadi M, Esmaeeli M, Pardakhty A (2019) Paclitaxel incorporated exosomes derived from glioblastoma cells: comparative study of two loading techniques. DARU J Pharm Sci 27:533\u2013539","journal-title":"DARU J Pharm Sci"},{"key":"1050_CR157","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.jconrel.2015.09.031","volume":"220","author":"H Saari","year":"2015","unstructured":"Saari H, L\u00e1zaro-Ib\u00e1\u00f1ez E, Viitala T, Vuorimaa-Laukkanen E, Siljander P, Yliperttula M (2015) Microvesicle-and exosome-mediated drug delivery enhances the cytotoxicity of Paclitaxel in autologous prostate cancer cells. J Controlled Release 220:727\u2013737","journal-title":"J Controlled Release"},{"key":"1050_CR158","doi-asserted-by":"publisher","first-page":"798","DOI":"10.3390\/cancers11060798","volume":"11","author":"C Melzer","year":"2019","unstructured":"Melzer C, Rehn V, Yang Y, B\u00e4hre H, von der Ohe J, Hass R (2019) Taxol-loaded MSC-derived exosomes provide a therapeutic vehicle to target metastatic breast cancer and other carcinoma cells. Cancers 11:798","journal-title":"Cancers"},{"key":"1050_CR159","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1478-811X-11-88","volume":"11","author":"TA Shtam","year":"2013","unstructured":"Shtam TA, Kovalev RA, Varfolomeeva EY, Makarov EM, Kil YV, Filatov MV (2013) Exosomes are natural carriers of exogenous siRNA to human cells in vitro. Cell Communication Signal 11:1\u201310","journal-title":"Cell Communication Signal"},{"key":"1050_CR160","first-page":"1953","volume":"17","author":"C Wang","year":"2019","unstructured":"Wang C, Chen L, Huang Y, Li K, Jinye A, Fan T, Zhao R, Xia X, Shen B, Du J (2019) Exosome\u2013delivered TRPP2 siRNA inhibits the epithelial\u2013mesenchymal transition of FaDu cells. Oncol Lett 17:1953\u20131961","journal-title":"Oncol Lett"},{"key":"1050_CR161","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1039\/D1BM01723C","volume":"10","author":"S-F Liang","year":"2022","unstructured":"Liang S-F, Zuo F-F, Yin B-C, Ye B-C (2022) Delivery of siRNA based on engineered exosomes for glioblastoma therapy by targeting STAT3. Biomaterials Sci 10:1582\u20131590","journal-title":"Biomaterials Sci"},{"key":"1050_CR162","doi-asserted-by":"publisher","first-page":"743013","DOI":"10.3389\/fmolb.2021.743013","volume":"8","author":"S Han","year":"2021","unstructured":"Han S, Li G, Jia M, Zhao Y, He C, Huang M, Jiang L, Wu M, Yang J, Ji X (2021) Delivery of anti-miRNA-221 for colorectal carcinoma therapy using modified cord blood mesenchymal stem cells-derived exosomes. Front Mol Biosci 8:743013","journal-title":"Front Mol Biosci"},{"key":"1050_CR163","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.3390\/pharmaceutics14081620","volume":"14","author":"M Zare","year":"2022","unstructured":"Zare M, Pemmada R, Madhavan M, Shailaja A, Ramakrishna S, Kandiyil SP, Donahue JM, Thomas V (2022) Encapsulation of miRNA and siRNA into nanomaterials for Cancer therapeutics. Pharmaceutics 14:1620","journal-title":"Pharmaceutics"},{"key":"1050_CR164","doi-asserted-by":"crossref","unstructured":"Guo ZY, Tang Y, Cheng YC (2024) Exosomes as targeted delivery drug system: advances in exosome loading, surface functionalization and potential for clinical application. Current Drug Delivery","DOI":"10.2174\/1567201819666220613150814"},{"key":"1050_CR165","first-page":"1835","volume":"19","author":"A Hassanzadeh","year":"2019","unstructured":"Hassanzadeh A, Naimi A, Hagh MF, Saraei R, Marofi F, Solali S (2019) Kaempferol improves TRAIL-mediated apoptosis in leukemia MOLT-4 cells by the inhibition of anti-apoptotic proteins and promotion of death receptors expression. Anti-cancer agents in Medicinal Chemistry (formerly current Medicinal Chemistry-Anti. -Cancer Agents) 19:1835\u20131845","journal-title":"-Cancer Agents)"},{"key":"1050_CR166","doi-asserted-by":"publisher","first-page":"354","DOI":"10.2174\/1574885516666210617162221","volume":"16","author":"S Rezapour","year":"2021","unstructured":"Rezapour S, Hosseinzadeh E, Jahangiryan A, Tapeh BE, Beheshtkhoo N, Kouhbanani MAJ, Hassanzadeh A, Marofi F (2021) Flavonoid kaempferol inhibits the proliferation and survival of human leukemia HL60 cells. Curr Drug Therapy 16:354\u2013363","journal-title":"Curr Drug Therapy"},{"key":"1050_CR167","doi-asserted-by":"publisher","first-page":"96","DOI":"10.4993\/acrt.29.96","volume":"29","author":"M Vahidi","year":"2021","unstructured":"Vahidi M, Noroozi-Aghideh A, Entezari A, Zamani M, Yaghoubi Y, Hassanzadeh A, Naimi A (2021) Quercetin elicits proapoptotic effect through downregulation of antiapoptotic and upregulation of proapoptotic genes in human myeloid leukemia KG-1 cells. Annals Cancer Res Therapy 29:96\u2013101","journal-title":"Annals Cancer Res Therapy"},{"key":"1050_CR168","doi-asserted-by":"crossref","unstructured":"Moghadasi S, Elveny M, Rahman HS, Suksatan W, Jalil AT, Abdelbasset WK, Yumashev AV, Shariatzadeh S, Motavalli R (2021) A paradigm shift in cell-free approach: the emerging role of MSCs-derived exosomes in regenerative medicine. 19:1\u201321Behzad FJJotm","DOI":"10.1186\/s12967-021-02980-6"},{"key":"1050_CR169","doi-asserted-by":"crossref","unstructured":"Hassanzadeh A, Hosseinzadeh E, Rezapour S, Vahedi G, Haghnavaz N, Marofi FJA-CAMC (2019) Quercetin promotes cell cycle arrest and apoptosis and attenuates the proliferation of human chronic myeloid leukemia cell line-K562 through interaction with HSPs (70 and 90), MAT2A and FOXM1. 19:1523\u20131534","DOI":"10.2174\/1871520619666190729150442"},{"key":"1050_CR170","doi-asserted-by":"publisher","first-page":"216093","DOI":"10.1016\/j.canlet.2023.216093","volume":"558","author":"R Raguraman","year":"2023","unstructured":"Raguraman R, Bhavsar D, Kim D, Ren X, Sikavitsas V, Munshi A, Ramesh R (2023) Tumor-targeted exosomes for delivery of anticancer drugs. Cancer Lett 558:216093","journal-title":"Cancer Lett"},{"key":"1050_CR171","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.yexmp.2016.05.013","volume":"101","author":"F Aqil","year":"2016","unstructured":"Aqil F, Kausar H, Agrawal AK, Jeyabalan J, Kyakulaga A-H, Munagala R, Gupta R (2016) Exosomal formulation enhances therapeutic response of celastrol against lung cancer. Exp Mol Pathol 101:12\u201321","journal-title":"Exp Mol Pathol"},{"key":"1050_CR172","first-page":"1769","volume":"6","author":"A Singh","year":"2021","unstructured":"Singh A, Sreenu B, Alvi S, Patnam S, Rajeswari K, Kutala V (2021) Bovine milk derived exosomal-curcumin exhibiting enhanced stability, solubility, and cellular bioavailability. Clin Oncol 6:1769","journal-title":"Clin Oncol"}],"container-title":["Journal of Physiology and Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13105-024-01050-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13105-024-01050-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13105-024-01050-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T10:08:24Z","timestamp":1735380504000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13105-024-01050-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,24]]},"references-count":172,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["1050"],"URL":"https:\/\/doi.org\/10.1007\/s13105-024-01050-x","relation":{},"ISSN":["1138-7548","1877-8755"],"issn-type":[{"value":"1138-7548","type":"print"},{"value":"1877-8755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,24]]},"assertion":[{"value":"19 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approcal"}},{"value":"There is no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}